Gel Tech

Gel-Tech was a pharmaceutical company primarily known for developing and commercializing the Zicam line of cold remedy products. The company's core innovation involved a unique hydrogel-based delivery system for ionic zinc, designed to be applied intranasally to reduce the duration and severity of the common cold. Following the success of its flagship product, the company underwent significant corporate restructuring and was eventually renamed Matrixx Initiatives. Its products became a staple in the over-the-counter cold and flu market before the company transitioned through various ownership stages, including private equity acquisition.